The levels of Cer d18:1/18:0, Cer d18:1/18:1, PS 16:0/18:1, and PS 18:1/18:1 were decreased after COR treatment in melanocytes, whereas these levels were increased after COR treatment in melanoma cells. The gene discussed is CBLN1; the disease is melanoma.